Journal News

The proteome of the cave bear

New metric helps researchers unlock strange samples
Laurel Oldach
Jan. 18, 2020

As a rule, it takes a genome to interpret a proteome.

A genome database gives the range of possible proteins that a sample is expected to contain, allowing a computer program to match short peptide fragments from the raw data to the full-length proteins they came from. The genome is like a picture showing how a jigsaw puzzle will look when it’s finished — and each peptide is a single tiny piece of the puzzle.

MCP-cave-bear-collage.png
Patty Blue Hayes, Jeffrey Weston Lotz,Jan Dembowski, Linda Snook
Among the exotic samples used in Richard Johnson’s study were, clockwise from top left, glacial meltwater; an agricultural pest called the citrus psyllid, which has a complex microbiome; a tenth of a gram of powdered cave bear bone; and electrosensory organs of the spotted ratfish and a skate (not pictured).

Richard Johnson, a staff scientist at the University of Washington’s department of genome sciences, has spent nearly three decades working with no picture. Before genomes were assembled and available, he became an expert in de novo peptide sequencing, piecing together the overlapping puzzle pieces from mass spectra to determine the amino acid sequence of proteins.

That ability has been coming in handy recently since Johnson started seeing more requests for environmental proteomics and other exotic analyses.

“I sit next to an oceanographer, and she does these proteomics analyses on strange samples, like glacial meltwater and seawater,” he said. “Those are cases where it’s really difficult to decide what database to even search.”

To annotate a sample from a human, a researcher can use a human genome database. But a tablespoon of ocean water or glacial runoff is likely to contain a complex community of microbes. So which genome databases should the researcher survey? Usually, researchers solve this problem by sequencing as much DNA as they can from a sample and using the result, a metagenome, to guide protein identification.

But even with a metagenome, sometimes the proteins observed in a proteomics experiment just don’t match the given reference database. “I came up with a metric that can tell you whether the protein sequence database is any good for interpreting your mass spectrometry data,” Johnson said.

The technique, which Johnson and colleagues recently published in Molecular & Cellular Proteomics, can be used to solve related problems, such as proteomic analysis of an animal whose genome has not been sequenced. “You typically use a sequence database from a closely related species and hope that the sequences did not diverge too much,” Johnson said. “Sometimes that hope is warranted, and other times it’s not.”

Johnson has used this approach to study the makeup of electrosensory organs in electric fish.

A third potential application is for analysis of very old but not fossilized tissues — those that come from extinct species, such as a vial of powdered cave bear bone that Johnson’s team obtained. Extinct species very rarely have a genome assembled, and the close-cousin conundrum is compounded by slow biochemical changes to proteins that happen over thousands of years.

But the approach doesn’t solve every problem. Johnson said, “Using this quality metric tells you how good or bad a sequence database is. But it won’t tell you what to do about it if it’s bad.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Light-activated small molecule could transform eye infection treatment
News

Light-activated small molecule could transform eye infection treatment

April 21, 2026

Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.

The molecular orchestra of memory
Feature

The molecular orchestra of memory

April 16, 2026

Calcium, calmodulin and calcium/calmodulin-dependent kinase II form a molecular axis that turns fleeting neural activity into lasting memories. New research shows how memories are stabilized, and possibly even protected or repaired.

Differences in pili structure modulate bacterial behavior
Journal News

Differences in pili structure modulate bacterial behavior

April 14, 2026

Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.